C225 epidermal growth factor receptor: Began two Phase Ib/IIa trials, one testing the agent alone, and the other combining it with cisplatin. Each 24-patient tr

ImClone Systems Inc. (IMCL), New York

Read the full 68 word article

How to gain access

Continue reading with a
two-week free trial.